Insiders · BTAI

BioXcel LLC

Company, not a person

Files as 10% owner at BioXcel Therapeutics, Inc. (BTAI)

BioXcel LLC is a company, not a person, and it has filed 3 insider reports with the SEC since March 2021, as 10% owner at BioXcel Therapeutics, Inc. (BTAI). BioXcel LLC made no open-market purchases or sales in the last 12 months. The latest filing, on June 4, 2024, is a Form 144 notice: BioXcel LLC plans to sell 252,028 BTAI shares (~$378K).

Filings
3
Companies
1
Bought on market
None
Sold on market
$14.6M

Companies where BioXcel LLC is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
BioXcel Therapeutics, Inc. logo
BTAI
BioXcel Therapeutics, Inc.
10% owner8,546,750$14.6MJun 4, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Other insiders at the same companies

Questions about BioXcel LLC

How many shares does BioXcel LLC own?
After the latest filing that states it, BioXcel LLC directly owned 8,546,750 shares of BioXcel Therapeutics, Inc. (BTAI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has BioXcel LLC bought or sold stock recently?
The most recent open-market sale was on June 25, 2021: sold 473,250 shares of BioXcel Therapeutics, Inc. (BTAI) for $14.6M at an average of $30.83.
How do I get alerts when BioXcel LLC files?
Follow BioXcel LLC on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by BioXcel LLC (SEC CIK 0001651990). Totals count each trade once, skipping amendments whose original is on file, from Mar 19, 2021 on. View on SEC EDGAR · Get this as JSON